|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Pediatrics, National Jewish Medical & Research Center, Denver, Colorado, United States
2 SRI International, Menlo Park, California, United States
3 Cardiovascular Research Institute, University of California San Francisco, San Francisco, California, United States; SRI International, Menlo Park, California, United States
* To whom correspondence should be addressed. E-mail: whitec{at}njc.org.
Rationale: Development of lung microvasculature is critical for distal airway formation. Both processes are arrested in the lungs of preterm newborns with bronchopulmonary dysplasia (BPD), a chronic form of lung disease. We hypothesized that activation of hypoxia-inducible factors (HIFs) augments lung vascular development. Objectives, Methods: Pulmonary angiogenic factors were assessed by quantitative real-time polymerase chain reaction, Western blot, and immunohistochemistry in preterm baboons (125d+14 d pro re nata O2 model) treated for 14 d with intravenous FG-4095, an inhibitor of prolyl hydroxylase domain-containing proteins (PHDs) which initiate HIF degradation. Main Results: HIF-1
, but not HIF-2
, mRNA and protein were increased (8-fold and 3-fold, respectively) in FG-4095 treated baboons relative to untreated controls. Expression of PHD-1, -2, and -3 was unchanged. Of note, mRNA and/or protein for platelet-endothelial cell adhesion molecule 1 (PECAM-1) and vascular endothelial growth factor (VEGF) were increased by FG-4095. Moreover, PECAM-1 expressing capillary endothelial cells detected by immunohistochemistry were augmented in FG-4095 treated baboons to levels comparable to those in fetal age-matched controls. Alveolar septal cell expression of Ki67, a proliferative marker, and VEGF were similar in untreated controls and FG-4095 treated neonates. Conclusions: These results indicate that HIF stimulation by PHD inhibition enhances lung angiogenesis in the primate model of BPD.
This article has been cited by other articles:
![]() |
F. A. Groenman, M. Rutter, J. Wang, I. Caniggia, D. Tibboel, and M. Post Effect of chemical stabilizers of hypoxia-inducible factors on early lung development Am J Physiol Lung Cell Mol Physiol, September 1, 2007; 293(3): L557 - L567. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. R. Grover, T. M. Asikainen, J. P. Kinsella, S. H. Abman, and C. W. White Hypoxia-inducible factors HIF-1{alpha} and HIF-2{alpha} are decreased in an experimental model of severe respiratory distress syndrome in preterm lambs Am J Physiol Lung Cell Mol Physiol, June 1, 2007; 292(6): L1345 - L1351. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Thebaud and S. H. Abman Bronchopulmonary Dysplasia: Where Have All the Vessels Gone? Roles of Angiogenic Growth Factors in Chronic Lung Disease Am. J. Respir. Crit. Care Med., May 15, 2007; 175(10): 978 - 985. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Groenman, M. Rutter, I. Caniggia, D. Tibboel, and M. Post Hypoxia-inducible Factors in the First Trimester Human Lung J. Histochem. Cytochem., April 1, 2007; 55(4): 355 - 363. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. M. Levesque, S. Zhou, L. Shan, P. Johnston, Y. Kong, S. Degan, and M. E. Sunday NPAS1 Regulates Branching Morphogenesis in Embryonic Lung Am. J. Respir. Cell Mol. Biol., April 1, 2007; 36(4): 427 - 434. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |